Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters-Reference-Cited by-同舟云学术

Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters

Published:1991-02 Issue:2-3 Volume:62 Page:54-58
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Nachbaur D. M.,Herold M.,Maneschg A.,Huber H.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01714900.pdf

Reference32 articles.

1. Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut BA (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73: 1915–1920

2. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimoto T, Takaku F, Akiyama Y (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 75: 1602–1605

3. Bataille R, Durie BGM, Grenier J (1983) Serum beta 2-microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. Br J Haematol 55: 439–442

4. Bataille R, Grenier J, Sany J (1984) Beta 2-microglobulin in myeloma: optimal use for staging, prognosis and treatment. A prospective study of 160 patients. Blood 63: 468–471

5. Bergui L, Schena M, Gaidano G, Riva M, Caligaris-Cappio F (1989) Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precorsors in multiple myeloma. J Exp Med 170: 613–619

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice;JCI Insight;2024-05-07

2. Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study;BMC Cancer;2024-04-26

3. Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice;2024-01-24

4. The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma;International Journal of Molecular Sciences;2023-12-31

5. Retiform purpura on the anterior lower body;JEADV Clinical Practice;2023-09-27